Primary Job Title Chief Financial Officer Primary Organization 
IOmx Therapeutics
Location Munich, Bayern, Germany Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
Investor Type
LinkedIn View on LinkedIn
Marcus is the Chief Financial Officer. He has a long-standing track record in this position either as employee or freelancer in the life science industry. Over the last years, he has been supporting several biotech and MedTech companies in different maturity stages. In 2001, he started his career in the life science industry as CFO of ProCorde GmbH
which merged with Trigen in 2006. He finally took over the responsibility for the whole Trigen Group as the sole member of the executive board of Trigen Holdings AG. Before joining ProCorde, Marcus worked in different industries, including financial controller in a German Chinese joint venture in the province Shandong in China. Marcus holds a degree in Business Administration from the University in Münster, Germany. Marcus was co-founder and CFO of Averitas Pharma Inc. (NJ) which was successfully sold to Gruenenthal.
